Screening for EGFR Amplifications with a Novel Method and Their Significance for the Outcome of Glioblastoma Patients

Glioblastoma is a highly aggressive tumour of the central nervous system, characterised by poor prognosis irrespective of the applied treatment. The aim of our study was to analyse whether the molecular markers of glioblastoma (i.e. TP53 and IDH1 mutations, CDKN2A deletion, EGFR amplification, chrom...

Descripción completa

Detalles Bibliográficos
Autores principales: Bieńkowski, Michał, Piaskowski, Sylwester, Stoczyńska-Fidelus, Ewelina, Szybka, Małgorzata, Banaszczyk, Mateusz, Witusik-Perkowska, Monika, Jesień-Lewandowicz, Emilia, Jaskólski, Dariusz J., Radomiak-Załuska, Anna, Jesionek-Kupnicka, Dorota, Sikorska, Beata, Papierz, Wielisław, Rieske, Piotr, Liberski, Paweł P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675194/
https://www.ncbi.nlm.nih.gov/pubmed/23762372
http://dx.doi.org/10.1371/journal.pone.0065444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675194/
https://www.ncbi.nlm.nih.gov/pubmed/23762372
http://dx.doi.org/10.1371/journal.pone.0065444

Ejemplares similares